The Latest Information

The Latest Information

May 29 2019

GenomeWeb Reports a feature story on QuanDx HPV testing by Dartmouth research group led by Dr. Tsongalis

Unexpected Prevalence of Rare High-Risk HPV Types Demonstrates Utility of Zeesan Biotech Assay in Low-Resource Setting

May 21 2019

QuanDx/Zeesan Biotech’s MeltPro High Risk HPV Genotyping Assay is Effective for Cervical Cancer Screening for Women in Low- and Middle-Income Countries

San Jose, CA, USA. May 21, 2019 – QuanDx is the designated U.S. distributor of a PCR-based assay from Zeesan Biotech designed to detect and identify the 14 high-risk genotypes of human papillomavirus (HPV). The MeltPro High-Risk HPV Genotyping Assay is a single-tube, multiplex real-time PCR-based test followed by high-resolution multi-color melting curve analysis. The ready-to-use lyophilized reagent is easy to ship and store; no dry ice is required.

Jan 11 2016

QuanDx Raises $3.0 Million in Series B2 Financing

San Jose, CA, USA. Jan. 11, 2016 QuanDx Inc., a biotechnology company developing and commercializing innovative molecular diagnostic tests for personalized cancer treatment, today announced that it has successfully completed its Series B2 financing round, raising $3.0 million. The funds will be used to continue development of the company’s proprietary platform technology and commercial program for molecular diagnostics in oncology, genetic diseases, and infectious diseases.

Nov 24 2015

QuanDx Announces Distribution Agreement for the Zeesan CE-IVD High Risk HPV Genotyping Assay

San Francisco, CA, USA. Nov. 24, 2015 QuanDx Inc., a biotechnology company developing and commercializing innovative molecular diagnostic tests for personalized cancer treatment, today announced that it has signed an worldwide agreement (excluding China) with Zeesan Biotech for the distribution of its MeltPro High Risk HPV Genotyping Assay.

Sep 24 2015

See you at AMP annual meeting in Austin, TX

San Francisco, CA, USA. Sept. 24th, 2015 QuanDx Inc., a biotechnology company developing and commercializing innovative molecular diagnostic tests for personalized cancer treatment, welcome you to stop by our Booth (#215) in Austin, TX.

Mar 10 2015

QuanDx Announces Appointment of Resnova S.r.l as its Italian Distribution Partner

Menlo Park, CA, USA. Mar. 10th, 2015 QuanDx Inc, a Biotechnology Company developing and commercializing innovative molecular diagnostic tests, announced that Resnova S.r.l. a Rome based distribution company having its main activity focus in the Research and advanced diagnostics field has been appointed as its authorized exclusive distributor in the Italian territory. With immediate effect, the QuanDx products will be available to all Italian customers exclusively through Resnova.

Cover Image for

Sitemap|Privacy Policy|Terms of Use

© QuanDx. All Rights reserved.

Contact Us

Toll Free in US
1-855-782-6392
1-855-QuanDx-Care

Info@Quandx.Com

Stay Connected